Science Explorer Back to mapMap
Discussion
Company · Mountain View · United States

Vivus (United States)

vivus.comROR OpenAlex
Research works
31
▼ 62% vs 2018-21
Citations
1.1k
34.3 per fractional work
Top-10% rate
10.1%
all institutions 10.0%
Open access
48%
world 40%
International
21%
world 18%
Vivus (United States)

Not ranked overall: Vivus (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Vivus (United States) work in?

In all years, 51% of research at Vivus (United States) is in Health Sciences, 25% in Social Sciences. Its largest fields are Medicine (49%), Engineering (9%), Social Sciences (8%). It does 1.8× the world's share of Health Sciences.

Health Sciences: 16 fractional works · 50.6% of its workMedicine: 15 fractional works · 48.5% of its workPharmacology: 4 fractional works · 11.7% of its workEndocrinology, Diabetes and Metabolism: 3 fractional works · 9.1% of its workPsychiatry and Mental health: 2 fractional works · 5.7% of its workGeriatrics and Gerontology: 1 fractional works · 3.8% of its workPhysiology: 1 fractional works · 3.5% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 3.2% of its workSurgery: 1 fractional works · 3.0% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 2.3% of its workUrology: 0 fractional works · 1.4% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 1.1% of its workRheumatology: 0 fractional works · 0.8% of its workAnesthesiology and Pain Medicine: 0 fractional works · 0.6% of its workFamily Practice: 0 fractional works · 0.6% of its workPulmonary and Respiratory Medicine: 0 fractional works · 0.6% of its workDermatology: 0 fractional works · 0.4% of its workBiochemistry: 0 fractional works · 0.3% of its workOncology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.4% of its workHealth Professions: 0 fractional works · 1.5% of its workGeneral Health Professions: 0 fractional works · 1.0% of its workPharmacy: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workDentistry: 0 fractional works · 0.6% of its workOral Surgery: 0 fractional works · 0.6% of its workSocial Sciences: 8 fractional works · 25.5% of its workSocial Sciences: 3 fractional works · 8.5% of its workPolitical Science and International Relations: 1 fractional works · 3.5% of its workSociology and Political Science: 1 fractional works · 2.4% of its workSafety Research: 0 fractional works · 0.8% of its workEducation: 0 fractional works · 0.7% of its workCultural Studies: 0 fractional works · 0.3% of its workDemography: 0 fractional works · 0.3% of its workUrban Studies: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workArts and Humanities: 2 fractional works · 5.7% of its workLiterature and Literary Theory: 1 fractional works · 2.4% of its workGeneral Arts and Humanities: 1 fractional works · 2.2% of its workReligious studies: 0 fractional works · 0.8% of its workPhilosophy: 0 fractional works · 0.3% of its workBusiness, Management and Accounting: 2 fractional works · 5.4% of its workMarketing: 1 fractional works · 3.3% of its workAccounting: 1 fractional works · 2.2% of its workEconomics, Econometrics and Finance: 1 fractional works · 3.3% of its workEconomics and Econometrics: 1 fractional works · 3.3% of its workPsychology: 1 fractional works · 2.4% of its workClinical Psychology: 1 fractional works · 2.4% of its workDecision Sciences: 0 fractional works · 0.2% of its workPhysical Sciences: 5 fractional works · 15.5% of its workEngineering: 3 fractional works · 9.4% of its workSafety, Risk, Reliability and Quality: 1 fractional works · 3.3% of its workBiomedical Engineering: 1 fractional works · 2.8% of its workCivil and Structural Engineering: 0 fractional works · 0.9% of its workMechanics of Materials: 0 fractional works · 0.9% of its workElectrical and Electronic Engineering: 0 fractional works · 0.7% of its workAerospace Engineering: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.4% of its workMaterials Science: 1 fractional works · 3.0% of its workMaterials Chemistry: 0 fractional works · 1.6% of its workBiomaterials: 0 fractional works · 0.8% of its workElectronic, Optical and Magnetic Materials: 0 fractional works · 0.3% of its workSurfaces, Coatings and Films: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workComputer Science: 1 fractional works · 2.2% of its workComputational Theory and Mathematics: 0 fractional works · 1.1% of its workComputer Vision and Pattern Recognition: 0 fractional works · 0.7% of its workComputer Networks and Communications: 0 fractional works · 0.2% of its workHardware and Architecture: 0 fractional works · 0.2% of its workChemistry: 0 fractional works · 0.4% of its workOrganic Chemistry: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workMathematics: 0 fractional works · 0.3% of its workStatistics and Probability: 0 fractional works · 0.3% of its workPhysics and Astronomy: 0 fractional works · 0.3% of its workAtomic and Molecular Physics, and Optics: 0 fractional works · 0.3% of its workLife Sciences: 3 fractional works · 8.4% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 4.4% of its workMolecular Biology: 1 fractional works · 3.0% of its workGenetics: 0 fractional works · 1.4% of its workAgricultural and Biological Sciences: 0 fractional works · 1.4% of its workForestry: 0 fractional works · 1.1% of its workAnimal Science and Zoology: 0 fractional works · 0.3% of its workImmunology and Microbiology: 0 fractional works · 1.2% of its workImmunology: 0 fractional works · 1.2% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.8% of its workToxicology: 0 fractional works · 0.4% of its workPharmaceutical Science: 0 fractional works · 0.4% of its workNeuroscience: 0 fractional works · 0.6% of its workDevelopmental Neuroscience: 0 fractional works · 0.6% of its workALL ITS WORKVivus (UnitedStates)31fractional works, all years
Life Sciences8%Physical Sciences16%Health Sciences51%Social Sciences25%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 20 fields, with their numbers
    1. Medicine1548.5%
    2. Health Professions01.5%
    3. Dentistry00.6%
    1. Social Sciences38.5%
    2. Arts and Humanities25.7%
    3. Business, Management and Accounting25.4%
    4. Economics, Econometrics and Finance13.3%
    5. Psychology12.4%
    6. Decision Sciences00.2%
    1. Engineering39.4%
    2. Materials Science13.0%
    3. Computer Science12.2%
    4. Chemistry00.4%
    5. Mathematics00.3%
    6. Physics and Astronomy00.3%
    1. Biochemistry, Genetics and Molecular Biology14.4%
    2. Agricultural and Biological Sciences01.4%
    3. Immunology and Microbiology01.2%
    4. Pharmacology, Toxicology and Pharmaceutics00.8%
    5. Neuroscience00.6%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Vivus (United States)?

Ranked on the quality score, Craig A. Peterson and Susamma Varghese lead among researchers whose main affiliation is Vivus (United States).

  1. 1 Craig A. Peterson United States · #1,409,446 worldwide 5.4k citations · 92 works
  2. 2 Susamma Varghese United States · #2,710,701 worldwide 11 citations · 36 works
All ranked researchers at Vivus (United States)

What are the most cited papers from Vivus (United States)?

The most cited paper from Vivus (United States) is "Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial" (Kishore M. Gadde, David Blair Allison, Donna H. Ryan et al., 2011), with 1,062 citations. Next come "Controlled‐Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP)" (725) and "Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study" (715).

Most cited papers
#PaperReleasedCitations
1 Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial Kishore M. Gadde, David Blair Allison, Donna H. Ryan et al. · The Lancet Apr 2011 1,062
2 Controlled‐Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP) David Blair Allison, Kishore M. Gadde, William Timothy Garvey et al. · Obesity Open access 3 Nov 2011 725
3 Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study William Timothy Garvey, Donna H. Ryan, Michelle Look et al. · American Journal of Clinical Nutrition Open access 8 Dec 2011 715
4 Treatment of Men with Erectile Dysfunction with Transurethral Alprostadil Harin Padma-Nathan, Wayne J.G. Hellstrom, Fran E. Kaiser et al. · New England Journal of Medicine Open access 2 Jan 1997 584
5 Evaluation of phentermine and topiramate versus phentermine/topiramate extended‐release in obese adults Louis J. Aronne, Thomas A. Wadden, Craig A. Peterson et al. · Obesity 17 Oct 2013 269
All 61 most cited papers, with filters and sorting

Which keywords describe research at Vivus (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Weight Loss, Clinical Trials, Obesity, Anti-Obesity Drugs, Pharmacotherapy, Cardiovascular Disease, Menopause and Type 2 Diabetes.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 35 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 35 words, with their numbers
  1. Clinical Trials4▲ 23×3 topics
  2. Weight Loss4▲ 90×3 topics
  3. Obesity4▲ 18×5 topics
  4. Anti-Obesity Drugs4▲ 495×1 topic
  5. Pharmacotherapy4▲ 467×1 topic
  6. Cardiovascular Disease2▲ 7.2×6 topics
  7. Menopause2▲ 156×2 topics
  8. Type 2 Diabetes2▲ 34×2 topics
  9. Psychological Interventions2▲ 42×2 topics
  10. Erectile Dysfunction2▲ 191×1 topic
  11. Sexual Dysfunction2▲ 191×1 topic
  12. Hormone Therapy2▲ 45×3 topics
  13. Cardiovascular Risk1▲ 13×2 topics
  14. Clinical Guidelines1▲ 15×2 topics
  15. Diabetes1▲ 9.1×3 topics
  16. Cardiovascular Outcomes1▲ 101×1 topic
  17. Glucose Control1▲ 101×1 topic
  18. Philosophy1▲ 9.6×2 topics
  19. Citizen Participation1▲ 36×2 topics
  20. European Union1▲ 17×2 topics
  21. Inappropriate Medication Use1▲ 95×1 topic
  22. Inflammation1▲ 1.61×5 topics
  23. Metabolic Syndrome1▲ 4.5×4 topics
  24. Polypharmacy1▲ 95×1 topic
  25. Public Administration1▲ 45×2 topics
  26. Quality of Life1▲ 2.8×6 topics
  27. Brand Trust1▲ 81×1 topic
  28. Breast Cancer1▲ 12×2 topics
  29. Consumer Behavior1▲ 8.9×1 topic
  30. Estrogen1▲ 44×2 topics
  31. Legal Studies1▲ 468×1 topic
  32. Medication Adherence1▲ 56×2 topics
  33. System Maturity1▲ 150×1 topic
  34. Technology Readiness Levels1▲ 150×1 topic
  35. Transparency1▲ 44×1 topic

Which research topics does Vivus (United States) publish most on?

By volume in 2022-now: Consumer Behavior in Brand Consumption and Identification, Pharmacology and Obesity Treatment, Bariatric Surgery and Outcomes and Diabetes Treatment and Management.

Consumer Behavior in Bra…1Consumer Behavior in Brand Consumption and Identification: 1 fractional worksPharmacology and Obesity Treatment: 0 fractional worksBariatric Surgery and Outcomes: 0 fractional worksDiabetes Treatment and M…0Diabetes Treatment and Management: 0 fractional works
MarketingPharmacologySurgeryEndocrinology, Diabetes and Metabolism

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Consumer Behavior in Brand Consumption and Identification Marketing 1 works
  2. 2 Pharmacology and Obesity Treatment Pharmacology 0 works
  3. 3 Bariatric Surgery and Outcomes Surgery 0 works
  4. 4 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 0 works
  5. 5 Gallbladder and Bile Duct Disorders Pulmonary and Respiratory Medicine 0 works
  6. 6 Cystic Fibrosis Research Advances Pulmonary and Respiratory Medicine 0 works
  7. 7 Pancreatitis Pathology and Treatment Surgery 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available48.2%not open51.8%

World: 40% of research is openly available.

with international co-authors20.6%domestic only79.4%

World: 18% is written across borders.

How has Vivus (United States)'s research output changed?

Output in 2022-2025 was 62% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Vivus (United States) as a percentage of every work published that year, 0.0000024% in 2023.

still counting0.00010%0.00020%Vivus (United States)0.000017% in 202519801990200020102020

Fractional works of Vivus (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Mountain View

All research institutions in Mountain View

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Vivus (United States). Posts are plain text and can be reported.